Pegfilgrastim biosimilar - Rus Biopharm
Latest Information Update: 21 Apr 2023
At a glance
- Originator Rus Biopharm
- Class Antineoplastics; Chemoprotectants; Granulocyte colony-stimulating factors; Polyethylene glycols; Radioprotectives; Recombinant proteins
- Mechanism of Action Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Neutropenia
Most Recent Events
- 24 Mar 2023 Registered for Neutropenia in Russia (SC), prior to March 2023 (Rus Biopharm pipeline, March 2023)